Clinical Trials Directory

Trials / Sponsors / European Myeloma Network B.V.

European Myeloma Network B.V.

Network · 17 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients Wi
Multiple Myeloma
Phase 32025-12-23
RecruitingStudy for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Ta
Multiple Myeloma (MM)
Phase 22025-12-12
RecruitingA Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloi
AL Amyloidosis
Phase 22025-07-02
RecruitingEuropean Myeloma Network (EMN) Sample Project
Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia
—2022-12-21
RecruitingPhase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone
Multiple Myeloma
Phase 32022-09-08
Active Not RecruitingA Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, an
Multiple Myeloma
Phase 32022-04-19
Active Not RecruitingIsa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
Multiple Myeloma
Phase 32020-09-25
CompletedA Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe
AL Amyloidosis
—2019-04-23
CompletedStudy of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients
Multiple Myeloma
Phase 1 / Phase 22014-06-01
CompletedPhase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22014-06-01
CompletedMaintenance Therapy With Subcutaneous Bortezomib
Multiple Myeloma
Phase 22013-11-01
CompletedStudy of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (
Multiple Myeloma
Phase 1 / Phase 22013-04-01
CompletedSequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation
Hematologic Malignancies, Multiple Myeloma
Phase 1 / Phase 22011-11-01
CompletedCarfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients
Multiple Myeloma
Phase 22011-07-01
CompletedA Trial for Systemic Light-chain (AL) Amyloidosis
AL Amyloidosis
Phase 32011-01-01
CompletedSubcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednis
Multiple Myeloma
Phase 22010-07-01
CompletedBortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia
Waldenstroms Macroglobulinemia
Phase 22006-09-01